Table 1. Cohort baseline characteristics of studying supraclavicular pCR after NAC.
| Variables | Total | Non-sPCR, n (%) | sPCR, n (%) | P | OR | 95% CI | P |
|---|---|---|---|---|---|---|---|
| Age, years | 0.55 | – | – | – | |||
| <50 | 44 | 17 (38.6) | 27 (61.4) | ||||
| ≥50 | 46 | 15 (32.6) | 31 (67.4) | ||||
| Menopause | 0.47 | – | – | – | |||
| No | 44 | 14 (31.8) | 30 (68.2) | ||||
| Yes | 46 | 18 (39.1) | 28 (60.9) | ||||
| Clinical T stage | 0.32 | – | – | – | |||
| T1–2 | 70 | 23 (32.9) | 47 (67.1) | ||||
| T3–4 | 20 | 9 (45.0) | 11 (55.0) | ||||
| ER | 0.16 | – | – | – | |||
| Negative | 34 | 9 (26.5) | 25 (73.5) | ||||
| Positive | 56 | 23 (41.1) | 33 (58.9) | ||||
| PR | 0.70 | – | – | – | |||
| Negative | 39 | 13 (33.3) | 26 (66.7) | ||||
| Positive | 51 | 19 (37.3) | 32 (62.7) | ||||
| HER2 | 0.27 | – | – | – | |||
| Negative | 55 | 22 (40.0) | 33 (60.0) | ||||
| Positive | 35 | 10 (28.6) | 25 (71.4) | ||||
| bPCR | <0.01 | 9.67 | 2.64–35.31 | <0.01 | |||
| No | 58 | 29 (50.0) | 29 (50.0) | ||||
| Yes | 32 | 3 (9.4) | 29 (90.6) | ||||
| aPCR | <0.01 | – | – | – | |||
| No | 47 | 25 (53.2) | 22 (46.8) | ||||
| Yes | 43 | 7 (16.3) | 36 (83.7) | ||||
| Platelet | 0.01 | – | – | – | |||
| ≤261.5 | 52 | 13 (25.0) | 39 (75.0) | ||||
| >261.5 | 38 | 19 (50.0) | 19 (50.0) | ||||
| Neutrophil | 0.10 | – | – | – | |||
| ≤3.36 | 43 | 19 (44.2) | 24 (55.8) | ||||
| >3.36 | 47 | 13 (27.7) | 34 (72.3) | ||||
| PLR | 0.03 | – | – | – | |||
| ≤129.60 | 42 | 10 (23.8) | 32 (76.2) | ||||
| >129.60 | 48 | 22 (45.8) | 26 (54.2) | ||||
| NLR | 0.05 | – | – | – | |||
| ≤1.51 | 28 | 14 (50.0) | 14 (50.0) | ||||
| >1.51 | 62 | 18 (29.0) | 44 (71.0) |